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Fiber type-specific programs controlled by the transcription 
factor MEF2 dictate muscle functionality. Here, we show that 
HDAC4, a potent MEF2 inhibitor, is predominantly localized to 
the nuclei in fast/glycolytic fibers in contrast to the sarco-
plasm in slow/oxidative fibers. The cytoplasmic localization is 
associated with HDAC4 hyper-phosphorylation in slow/oxi- 
dative-fibers. Genetic reprogramming of fast/glycolytic fi-
bers to oxidative fibers by active CaMKII or calcineurin leads 
to increased HDAC4 phosphorylation, HDAC4 nuclear ex-
port, and an increase in markers associated with oxidative 
fibers. Indeed, HDAC4 represses the MEF2-dependent, PGC-
1α-mediated oxidative metabolic gene program. Thus differ-
ential phosphorylation and localization of HDAC4 contrib-






Skeletal muscle is composed of heterogeneous myofibers with 
different contractile and metabolic properties. This arrangement 
enables skeletal muscle to effectively carry out different tasks, 
from maintaining body posture to performing rapid movements. 
Myofibers are grossly classified into slow/oxidative fibers and 
fast/glycolytic fibers. The slow/oxidative fibers are more re-
sistant to fatigue, rich in mitochondria, and preferentially use 
oxidative phosphorylation to provide ATP for contraction (thus 
termed oxidative fibers). The fast/glycolytic fibers, in contrast, 
are fast in contractility, contain fewer mitochondria and use 
glycolysis as the main source of energy (Spangenburg and 
Booth, 2003). The functionality of a myofiber is determined by 
the expression of unique sets of contractile proteins and meta-
bolic enzymes at the transcriptional level. Thus, in slow fibers, 
type I myosin heavy chain (MHC) is the dominant form of myo-
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sin heavy chain, while in fast fibers type IIb or IIx MHC are the 
main isotypes (Spangenburg and Booth, 2003). In terms of the 
metabolic program, the transcriptional co-factor peroxisome 
proliferator-activated receptor-γ coactivator-1α (PGC-1α) is 
expressed at higher levels in slow/oxidative fibers and is a ma-
jor regulator of the mitochondrial oxidative phosphorylation 
program (Lin et al., 2002). 
Adult skeletal muscle is highly adaptive and can undergo 
changes in contraction, metabolism, and size to meet a variety 
of functional demands [reviewed in (Bassel-Duby and Olson, 
2006)]. Established and subsequent re-programming of fiber-
specific gene transcription has important physiological and 
pathological implications. In metabolic diseases (i.e. diabetes 
and metabolic syndrome) a slow/oxidative-to-fast/glycolytic fiber 
transition correlates with disease severity (Marin et al., 1994; 
Nyholm et al., 1997; Schrauwen and Hesselink, 2004). Con-
versely, endurance training promotes a more oxidative muscle 
fiber phenotype reflecting a transformation from type IIx/IIb to 
IIa (Fitzsimons et al., 1990; Pette, 2002). The transition to oxi-
dative fibers involves PGC-1α, which promotes oxidative ener-
gy utilization and mitochondria biogenesis through the co-
activation of MEF2-dependent gene expression (Lin et al., 
2002). Supporting its instructive role in specifying the fiber type 
program, paradigms that promote slow/oxidative fiber formation 
(e.g. endurance training) frequently induce PGC-1α expression 
(Terada et al., 2002; Russell et al., 2003; Sandri et al., 2006). In 
fact, PGC-1α over-expression can convert fast/glycolytic fibers 
to slow/oxidative fibers in a mouse model (Lin et al., 2002). 
Promoter analysis and cell-based studies have identified MEF2 
as a key transcriptional activator for PGC-1α expression in 
skeletal muscle (Akimoto et al., 2004b; Czubryt et al., 2003). 
Consistent with this proposal, MEF2 is selectively more active 
in slow/oxidative than fast/glycolytic fibers (Wu et al., 2000; 
2001). The molecular mechanism that differentially regulates 
the MEF2-PGC-1α transcriptional program in slow vs fast 
myofibers has not been fully elucidated. 
HDAC4 is the founding member of the class IIa HDACs, best 
known for their ability to bind and repress MEF2 (Black and 
Olson, 1998; McKinsey et al., 2000; Zhao et al., 2001). Despite 
its potent inhibitory activity on MEF2, HDAC4 is expressed in 
terminally differentiated skeletal muscles where MEF2 activity is 
essential (Choi et al., 2012; Cohen et al., 2007; Potthoff et al., 
2007a). This finding indicates that HDAC4 is likely subjected to 
negative regulation, allowing MEF2-dependent muscle gene 
transcription. Analysis of HDAC members in skeletal muscle 
has indicated that protein levels of class IIa HDACs, including 
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fast/glycolytic fibers (Potthoff et al., 2007b). Reduced abundance 
of class IIa HDAC members could certainly contribute to elevated 
MEF2 activity observed in slow/oxidative fibers. On the other 
hand, cell-based analyses have also convincingly demonstrated 
that phosphorylation of HDAC4 by calcium/ calmodulin-
dependent kinases (CaMKs) or other kinases activate HDAC4 
nuclear export, leading to de-repression/activation of MEF2 target 
genes (Backs et al., 2006; Cohen et al., 2009; McKinsey et al., 
2000; 2002; Vega et al., 2004; Zhao et al., 2001). The intracellu-
lar movement of HDAC4, in principle, could also modulate MEF2 
activity. Whether phosphorylation-dependent intracellular traffick-
ing of HDAC4 is involved in the MEF2-dependent and fiber type-
specific transcriptional program is not known. 
In this report, we present evidence that HDAC4 is differentially 
phosphorylated and localized in distinct subcellular compart-
ments of different muscle types. In fast/glycolytic fibers, HDAC4 
is less phosphorylated and more nuclearly localized whereas in 
slow/oxidative fibers, the opposite phenotype is observed. Sup-
porting its functional relevance to MEF2-dependent fiber type-
specific transcription, we show that HDAC4 inhibits slow fiber-
specific gene transcription and its phosphorylation leads to 
nuclear exclusion and activation of markers for slow/oxidative 
fibers. Our results implicate a regulatory role for HDAC4 in the 
maintenance and/or reprogramming of fiber type-specific gene 
transcription in adult skeletal muscle. 
 
MATERIALS AND METHODS 
 
Cell culture/plasmids/antibodies 
C2C12 myoblasts were cultured in 20% FBS/DMEM and differ-
entiated in 2% horse serum/DMEM. Stable myoblast lines were 
used as described previously (Cohen et al., 2009). GFP-CaMKII 
plasmid was from Dr. Anthony Means (Duke University) and the 
T287D mutant was generated by the standard protocol for PCR-
mediated mutagenesis, with the mutant confirmed via DNA se-
quencing. MHC I and IIb reporters were provided by Dr. Steven 
Swoap (Williams College). PGC-1α reporters were from Dr. 
Bruce Spiegelman (Addgene plasmid database). The following 
antibodies were used: MY-32 antibody from Sigma; cytochrome 
c and COX IV antibodies from BD Bioscience; GFP antibody 
from Santa Cruz; myogenin and tubulin antibodies from Sigma; 
BAF-8 antibody (Akimoto et al., 2004a); and GAPDH antibody 
from Cell Signaling. HDAC4 (clone 186) and P467-HDAC4 (clone 
19111) antibodies were previously described (Cohen et al., 2007). 
 
Mouse procedures 
C57BL/6 mice were purchased from Jackson Laboratory. 
Calcineurin mice were used as described previously (Naya et 
al., 2000). In vivo electroporation of siRNAs or plasmids to TA 
muscle were performed as described previously (Cohen et al., 
2007; 2009). HDAC4 siRNA sequences were as follows (Invi-
trogen): 5′-CACCGGAACCUGAACCACUGCAUUU-3′. Briefly, 
mice were anesthetized with a ketamine/xylazine mixture. After 
removing hair, 200 pmol of siRNAs or 25 μg of plasmids, in-
cluding 5 μg of GFP plasmid to identify electroporated fibers, 
were injected into TA muscles using cemented MicroSyringe 
(VWR). An ECM830 electroporator (BTX) was used for 
electroporations. Mice were allowed to recover in their cages. 
All mice were housed in at the Duke University mouse facilities, 
and all animal procedures were approved by the Institutional 
Animal Care and Use Committee at the Duke University. 
 
RNA analysis 
RNA extraction and qRT-PCR were performed as described 
previously (Cohen et al., 2009). For RNA analysis, GFP-positive 
fibers were isolated using a dissecting microscope. Muscles 
were lysed in Tri regent and RNA was extracted by standard 
protocols. cDNA was synthesized using iScript RT kit (Bio-Rad). 
Real-time PCR was performed using iQ Syber Green Supermix 
on the iCycler iQ detection system (Bio-Rad). PCR primer se-
quences are as follows: actin: 5′-ACCCAGGCATTGCTGACA-
GGATGC-3′ and 5′-CCATCTAGAAGCATTT-GCGGTGGACG-
3′, PGC-1α: 5′-CGATGTGTCGCCTTCTTGCT-3′ and 5′-CGA-





Muscles and C2C12 myotubes were lysed as described previ-
ously (Cohen et al., 2007; 2009). Muscles were dounce-
homogenized in lysis buffer (0.05 M NaCl, 0.02 M Tris, pH 7.6, 
1 mM EDTA, supplemented with leupeptin, aprotinin, 
phenylmethylsulfonyl fluoride, NaF, sodium orthovanadate, and 
1 mM dithiothreitol). Lysates were then incubated with 1X de-
tergent (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) by 
adding 10X stock solution. C2C12 myotubes were harvested at 
indicated time points and lysed in 150 mM NETN buffer (0.5% 
NP-40, 20 mM Tris, pH 8.0, 1 mM EDTA, and 150 mM NaCl) 
for 30 min on ice and centrifuged. Lysates were subjected to 
Western blotting using SDS-PAGE, transferred to membranes, 
and incubated with indicated antibodies. 
 
Immunofluorescence 
Muscle staining was performed as described previously (Cohen 
et al., 2007; 2009). Mouse muscles were dissected, frozen by 
OCT solution (Tissue-Tek) in methylbutane chilled in liquid 
nitrogen, and cryosectioned. Cross-sections were fixed for 10 
min in 4% paraformaldehyde. After washing with PBS, sections 
were blocked in 5% normal goat serum (NGS) for 2 h at room 
temperature and incubated with primary antibodies overnight. 
Sections were washed in PBS, blocked with NGS for 1.5 h, and 
incubated with secondary antibody. Nuclei were stained using 
Hoechst dye. Sections were imaged using a Zeiss Axioscope 
compound microscope (Carl Zeiss). 
 
Luciferase assay 
Luciferase assay was performed as described previously 
(Cohen et al., 2009). Brie y, C2C12 myofl blasts were plated at 
20,000 cells per well in a 24-well plate. Each reporter was co-
transfected with β-gal in combination with the plasmids using 
Fugene (Promega). Myoblasts were then differentiated in 2% 
horse serum/DMEM. Myotubes were lysed in luciferase lysis 
buffer (50% glycerol, 2.5% TX-100, 3 g Tris base, and 0.695 g 
CDTA per 200 ml, pH 7.8) for 20 min at room temperature. Ten 
μl of cell lysate was used with 200 μl of luciferase assay buffer 
(15 mM MgSO4, 15 mM K2HPO4, 4 mM EGTA, 1 mM DTT, and 
1 mM ATP). For normalization, 20 μl of lysate was used in β-gal 
assay (10 mg ONPG, 17 μl of β-mercaptoethanol per 5 ml Z-




More cytoplasmic localization of HDAC4 is present in 
slow/oxidative muscle fiber 
Given that MEF2 is more active in slow/oxidative fibers, we 
hypothesized that its repressor, HDAC4, would be inactivated 
in slow/oxidative fibers. Since nuclear export of HDAC4 leads 
to MEF2 activation, we investigated if HDAC4 shows differential 
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Fig. 1. Distinct subcellular localization of HDAC4 in slow and fast 
muscle fibers. HDAC4 localization was determined by 
immnostaining slow soleus (Sol) and neighboring fast-rich gas-
trocnemius (GA) muscles. Frozen muscle cross-sections were co-
stained with HDAC4 and fast myosin-specific antibodies. GA and 
Sol muscles are marked as G and S, respectively. DNA is visual-




localization in myofibers (Fig. 1). Immuonostaining with an 
HDAC4-specific antibody revealed a distinct pattern where 
more cytosolic staining of HDAC4 was observed in the 
slow/oxidative fiber-enriched soleus (Sol) muscle as opposed to 
the predominantly nuclear localization of HDAC4 in the adja-
cent fast/glycolytic fiber-rich gastrocnemius (GA) muscle. This 
result indicates that HDAC4 mainly resides in the cytosol of 
slow/oxidative fibers, which would activate MEF2-dependent 
transcription. 
 
HDAC4 phosphorylation and cytosolic accumulation are 
induced by transgenes that activate slow/oxidative fibers  
To investigate if differential HDAC4 phosphorylation is a char-
acteristic feature of different myofibers, we examined muscles 
from transgenic mice expressing a MCK-driven, constitutively-
activated calcineurin (CN) transgene, which induces slow/ oxi-
dative fiber formation in normally fast/glycolytic fiber-dominant 
muscles (Chin et al., 1998). As shown in Fig. 2A, while HDAC4 
was more abundantly phosphorylated on S467, a target of 
CaMKII (Backs et al., 2006), in Sol muscle than in fast-type 
muscles in control mice, HDAC4 phosphorylation was markedly 
induced in all fast fibers analyzed, including plantaris (PL), 
tibialis anterior (TA), and white vastus (WV) muscle from CN-
transgenic mice. This result indicates that HDAC4 phosphoryla-
tion positively correlates with the slow/oxidative fibers com-
pared to fast/glycolytic fibers. 
Constitutively-active CaMK also induces slow/oxidative fibers 
(Wu et al., 2002). CaMKII has been shown to bind and phos-
phorylate HDAC4, resulting in its cytoplasmic localization (Backs 
et al., 2006). KN-62, a CaMK inhibitor, can block cytoplasmic 
translocation of HDAC4 induced by electrical stimulation in 
isolated myofibers (Liu et al., 2005). We confirmed that HDAC4 
phosphorylation (S467) was indeed increased by CaMKII acti-
vation in cultured cells (Fig. 2B). To investigate whether CaMKII 
activation promotes HDAC4 phosphorylation and cytoplasmic 
translocation in skeletal muscle, we electroporated a constitu-
tively active CaMKII-T287D plasmid into wild-type mouse TA 
muscle. Increased accumulation of phospho-HDAC4 was ob-






















Fig. 2. Increased phosphorylation and cytoplasmic accumulation of 
HDAC4 by calcineurin or CaMKII activation. (A) Increased phos-
phorylation of HDAC4 was observed in calcineurin (CN) transgenic 
mouse muscles that acquired a fast-to-slow fiber type conversion. 
Muscles were collected from control and CN mice and muscle ly-
sates from slow Sol and fast fibers including plantaris (PL), tibialis 
anterior (TA), and white vastus (WV) were analyzed by Western 
blot analysis with the indicated antibodies. (B) Increased HDAC4 
phosphorylation at Ser-467 was confirmed by constitutively active 
CaMKII-T287D expression in Cos-7 cells. (C) Increased HDAC4 
phosphorylation at Ser-467 correlated with expression of oxidative 
gene markers in TA muscle expressing CaMKII-T287D. Muscle 
lysates were subjected to Western blot analysis using the indicated 
antibodies. (D) Sub-cellular localization of HDAC4 and phospho-
HDAC4 was determined by immunostaining analysis of frozen 
cross-sections from GFP-CaMKII-T287D-transfected TA muscles. 
The asterisk indicates CAMKII transfected fibers with peripheral 
HDAC4 accumulation similar to phospho-HDAC4. The arrowheads 
depict clear regions of membranous and cytoplasmic phospho-
HDAC4 accumulation in CAMKII transfected fibers in contrast to 
neighboring untransfected fibers. Note the overall increased phos-
phorylation of HDAC4 with specific immunoreactivity along the 




(Fig. 2C) and immuno-staining (Fig. 2D). Importantly, an enri-
chment of phospho-HDAC4 along the muscle periphery be-
came apparent in CaMKII-T287D-positive myofibers (Fig. 2D, 
arrows), suggesting an increase in HDAC4 nuclear export. 
Indeed, mitochondrial oxidative markers, including Cytochrome 
C and Cox IV, were induced in CaMKII-T287D-positive 
myofibers (Fig. 2C). In untransfected myofibers, HDAC4 signal 
was more concentrated to the nuclei (Fig. 2D). Together, these 
results indicate that phosphorylation increases HDAC4 cyto-
plasmic relocalization and oxidative gene expression in skeletal 
muscle. 
 
HDAC4 represses slow/oxidative fiber gene expression 
Nuclear HDAC4-enriched fast fibers suggested that it might 
repress the MEF2-dependent slow/oxidative fiber gene expres-
sion. To test this possibility, C2C12 myoblasts stably express-
ing a HDAC4 siRNA with or without re-expressing an HDAC4 
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Fig. 3. HDAC4 inhibits slow fiber MHC expression in cultured 
myotubes. (A) C2C12 myoblast controls or those stably expressing 
an HDAC4 siRNA (KD) or re-expressing HDAC4 wild type (Rescue) 
were differentiated for indicated time points and cell lysates were 
subjected to Western blot analysis using indicated antibodies 
against slow and fast myosin heavy chains (MHC), I and IIs, re-
spectively. (B) C2C12 myotubes stably expressing an HDAC4 
siRNA or re-expressing HDAC4 wild type plasmid were analyzed 
for promoter-driven luciferase activities using MHC I and IIb-specific 
reporter constructs. Columns, mean; Bars, SD (n = 3). ***P < 0.001 
versus control siRNA. (C,D) Expression of slow and fast MHC I and 
II in C2C12 myotubes treated with HDAC4 inhibitors. C2C12 
myotubes were treated overnight with the indicated concentrations 
of trichostain A (TSA) or valproic acid (VPA) in a dose-dependent 





plasmid were differentiated into myotubes, and the expression 
of slow-fiber MHC I and fast fiber MHC II was determined. As 
shown in Fig. 3A, HDAC4 knockdown (KD) or HDAC4 re-
expression (Rescue) did not have a significant effect on C2C12 
differentiation as indicated by myogenin induction, thus sug-
gesting that modulating HDAC4 expression does not alter the 
differentiation program per se, but rather specifically regulates 
MEF2 target gene expression (Cohen et al., 2009; Zhao et al., 
2001;). However, the expression of slow-fiber MHC I (BAF-8) 
was elevated by HDAC4 KD and suppressed by the re-
expression of HDAC4. Consistent with this finding, HDAC4 KD 
significantly increased promoter activity of MHC I, whereas 
HDAC4 re-expression suppressed this activity (Fig. 3B). 
HDAC4 expression levels did not have a significant effect on 
MHC II expression (Fig. 3A, MY-32) or its promoter activity (Fig. 
3B). These results indicate a preferential effect of HDAC4 in 
preventing slow fiber-specific MHC I expression in C2C12 cells. 
We next investigated whether HDAC inhibitors, valproic acid 
(VPA) and trichostatin A (TSA), alone can differentially affect 
MHC I expression. Consistent with HDAC4 being a negative 
regulator of MHC I, a dose-dependent increase in MHC I was 
observed in VPA- and TSA-treated C2C12 cells (Figs. 3C and 
3D). Interestingly, HDAC inhibitors decreased MHC II expres-
sion. These findings reveal that HDAC inhibitors can affect fiber 
type-specific MHC expression in cultured muscle cells. 
Since MEF2 and PGC-1α expression positively regulates ox-
idative gene expression (Lin et al., 2002; Potthoff et al., 2007b), 
we next examined whether HDAC4 regulates PGC-1α 




























Fig. 4. HDAC4 inhibits MEF2-dependent expression of PGC-1α 
and related oxidative genes. (A) Tibialis muscles (TA) were 
electroporated with expression plasmids containing control, wild 
type HDAC4, or the nuclear-localized HDAC4-3SA mutant and 
oxidative gene expression was evaluated by RNA analysis of iso-
lated TA muscle lysates by real-time RT-PCR. Oxidative gene ex-
pression was determined using gene-specific primers detecting 
PGC-1α, and myoglobin, all of which are up-regulated in slow-fibers. 
Values represent fold repression relative to actin levels. Columns, 
mean; bars, SEM (n = 3). *P < 0.05. (B) RNA analysis similar to 
panel A was performed to monitor oxidative gene expression after 
HDAC4 siRNA knockdown in TA muscles. Columns, mean; bars, 
SEM (n = 3). *P < 0.05. (C) PGC-1α promoter luciferase activities 
were evaluated in transfected myotubes using wild-type PGC-1α or 
a mutant promoter containing deletion of AT-rich elements harbor-
ing MEF2-binding sites (deltaMEF2). HDAC4 suppressed PGC-1α 
promoter activity in a MEF2-dependent manner. (D) MEF2 promot-
er activity was examined in transfected myotubes using wild-type 




gene expression. To this end, we electroporated wild type and 
constitutively nuclear HDAC4-3SA mutant (Zhao et al., 2001) 
into TA muscles. As shown in Fig. 4A, PGC-1α expression was 
modestly repressed by wild-type HDAC4, while more prominent 
repression was observed by the HDAC4-3SA mutant. The 
relatively modest effect of ectopic wild-type HDAC4 could be 
due to endogenous HDAC4 enrichment in the nuclei of TA 
muscle. Supporting a repressive activity of HDAC4 on PGC-1α-
dependent oxidative programming, knockdown of HDAC4 by a 
siRNA in TA muscle led to elevated expression of PGC-1α, 
myoglobin and Cytochrome C (Fig. 4B). Furthermore, HDAC4 
repressed PGC-1α promoter activity in a MEF2-dependent 
manner, as deletion of AT-rich MEF2-binding elements pre-
vented HDAC4-mediated repression of PGC-1α (Fig. 4C). Con-
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firming that HDAC4-mediated transcriptional repression occurs 
via a nuclear mechanism, both wild-type HDAC4 and most 
robustly, the nuclear-targeted HDAC4-3SA mutant, strongly 
suppressed MEF2 promoter activity (Fig. 4D). Collectively, 
these results indicate that HDAC4 establishes fast fiber gene 
expression via repression of MEF2-dependent PGC-1α and 




In this study, we provide evidence that nuclear HDAC4 is in-
volved in the repression of oxidative gene expression that spec-
ifies slow fiber fate. Although it was previously reported that 
HDAC4 levels were markedly reduced in slow/oxidative fibers 
(Potthoff et al., 2007b), our results showed that HDAC4 was 
more abundant in the slow/oxidative Sol muscle compared to 
the fast/glycolytic muscles (Figs. 1 and 2A). These findings are 
consistent with a previous report (Liu et al., 2005), which 
demonstrated HDAC4 cytoplasmic translocation, and not deg-
radation, in response to slow fiber patterns of electrical stimula-
tion. The basis of this discrepancy is not known, but could pos-
sibly be due to different experimental conditions such as strin-
gency of muscle lysis buffer. In slow Sol muscle, cytoplasmic 
HDAC4 was dominant, in contrast to fast fiber-rich GA muscle 
(Fig. 1). Accordingly, the more cytoplasmic localization of 
HDAC4 would permit more active MEF2-dependent oxidative 
gene expression. Indeed, conversion of fast/glycolytic fibers to 
more oxidative fibers by calcineurin transgene expression led to 
an increase in HDAC4 phosphorylation (Fig. 2A). Further sup-
porting a role of HDAC4 phosphorylation in specifying the oxi-
dative fiber phenotype, we also observed that CaMKII activa-
tion in TA muscle caused the induction of several oxidative 
markers, which correlated with HDAC4 phosphorylation and 
subsequent cytoplasmic translocation (Figs. 2C and 2D). These 
findings are also in agreement with a previous in vitro analysis 
showing that slow-twitch fiber activation by electrical stimulation 
of myofibers causes cytoplasmic translocation of HDAC4 lead-
ing to MEF2 activation (Liu et al., 2005). Thus, our results sug-
gest that dynamic HDAC4 phosphorylation and subcellular re-
localization might be involved in maintaining and re-
programming muscle fiber functionality in adult muscle. 
Multiple signaling networks collaborate to ensure proper fi-
ber-type specification based on the physiological demand of 
the muscle. Further studies would be required to determine 
the role of HDAC4 in adult muscle remodeling. It is important 
to point out that inactivation of HDAC4 alone is not capable of 
“switching” fiber-types in vivo (Potthoff et al., 2007b), which 
reflects the functional redundancy of class IIa HDACs. Indeed, 
the closely-related HDAC5 can also suppress MEF2-
dependent PGC-1α expression and is subjected to phosphor-
ylation-dependent nuclear export (Czubryt et al., 2003; Vega 
et al., 2004). Thus, HDAC4 likely collaborates with other class 
IIa members in fiber type specification and oxidative gene 
expression. Consistent with this possibility, we noticed that 
pan-HDAC inhibitor treatment causes a reduction of MHC II 
fiber specific MHC and concurrent induction of MHC I fiber 
MHC in C2C12 myotubes (Figs. 3C and 3D). Indeed, HDAC 
inhibitor treatment in vivo using a mouse model of muscular 
dystrophy was previously shown to prevent muscle degenera-
tion associated with fast fiber conversion (Minetti et al., 2006). 
Given that exercise tends to increase slow/oxidative fibers, 
whether HDAC inhibitors can similarly promote a 
slow/oxidative fiber transition in vivo and improve muscle 
functionality profile requires future study. 
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